GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $78,512,000 | +635.5% | 1,152,900 | +245.1% | 0.23% | +656.7% |
| Q2 2022 | $10,674,000 | +249.4% | 334,100 | +278.8% | 0.03% | +275.0% |
| Q1 2022 | $3,055,000 | +399.2% | 88,200 | +809.3% | 0.01% | +300.0% |
| Q2 2020 | $612,000 | -25.6% | 9,700 | -39.8% | 0.00% | -33.3% |
| Q1 2020 | $823,000 | -87.1% | 16,100 | -79.9% | 0.00% | -80.0% |
| Q4 2019 | $6,383,000 | – | 80,296 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |